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ABSTRACT 
Background: Type I diabetes (T1D) is the most common form of diabetes in most parts of the world.Aim: The association between 
cytomegalovirus (CMV)and T1D mellitus was studied, with comparison to healthy subjects and to correlate its level with different 
clinical and laboratory parameters. 
Materials & Methods: This study included 68 children and adolescents who were classified into two groups. GroupI comprised 53 
patients diagnosed with T1D and having regular follow up in the pediatric endocrinology out-patient clinic, Minia University 
children's hospital. Group II comprised 15 apparently healthy subjects, age and sex matched to the diseased group. According to the 
onset of diabetes, we divided the diabetic group into two sub-groups. Group Ia (newly diagnosed) comprised 20 patients, with ages 
ranging between 7 and 18 years; 10 were males (50 %), and 10 were females (50 %). Whilst group Ib (duration of disease >1 year) 
comprised 33 patients, with ages ranging between 6 and 17 years; 17 were males (49%) and 18 were females (51%). The studied 
groups were subjected to the following: thorough history taking, clinical examination and laboratory investigations (random blood 
glucose levels) and HbA1c%. DNA was extracted using QIAamp Min elute kit protocol for detection of cytomegalo virus by RT-
RCR. 
Results:The frequency of cytomegalovirus was significantly higher in T1D children than the control and in group Ia than group Ib. 
Conclusion: T1D children had significantly higher serum cytomegalovirus than the control group, as did those newly diagnosed 
compared to those with longer duration of illness. 
Keywords:T1D, Cytomegalo-virus, Haemoglobin A1C, Polymerase chain reaction 
Key Messages: Dose of insulin, significant +ve correlations, RT-PCR 
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RESUME 
Contexte : Diabète de type 1(DT1) est la forme la plus courante du diabète dans la plupart des régions du monde. 
But : L’association entre le cytomégalovirus et DT1 sucre a été étudiée avec une comparaison aux sujets sains et pour 
corréler son niveau avec les divers paramètres cliniques et laboratoires. 
Matériaux et Méthodes : Cette étude a inclus 68 enfants et adolescents qui ont été classés en deux groupes. Le Groupe I a 
compris 53 patients diagnostiqués avec DT1 et ayant suivi régulier dans la clinique endocrinologie pédiatrique 
ambulatoire, l’Université hôpital d’enfants de Minia. Le Groupe II a compris 15 sujets apparemment sains, l’age et le 
sexe adapté au groupe malade. Selon l’attaque du diabète, nous avons divisé le groupe diabétique en deux sous – 
groupes. Le Groupe Ia (nouvellement diagnostiqué), a compris 20 patients, dont l’âge est compris entre 7 et 18 ans ; 10 
étaient males (50%), et 10 étaient femelles (50%). Alors que le Groupe Ib (la durée de malade >1 ans) comprenait 33 
patients ; 17 étaient males (49%), et 18 étaient femelles (51%). Les groupes étudiés ont été soumis a la suivante : grâce a la 
prise de l’histoire, examen clinique et examen de laboratoire (nouveau de glycémie aléatoire) et HbA1c%. L’ADN a été 
extrait en utilisant QIAamp  Min elute protocole du kit pour le dépistage du cytomégalovirus par RT – RCR. 




Résultats : La fréquence du cytomégalovirus était considérablement plus élevée dans les enfants DT1 que le contrôlé et 
dans le Groupe Ia que le Groupe Ib. 
Conclusion : Les enfants DT1 ont eu sérum cytomégalovirus  plus élevé que le groupe contrôlé, comme ceux 
nouvellement diagnostiqués par rapport a ceux qui ont une plus longue durée de la malade. 
Mots Clés : DT1, Cytomégalovirus, Hémoglobine A1C, la réaction en chaine de la Polymérase. 
Messages Clés : Dose d’insuline, Significative +ve corrélations, RT – PCR. 
 
INTRODUCTION 
Type I diabetes (T1D) is the most common form of 
diabetes in most parts of the world; variations exist 
between the incidence rates of different populations. 
In type 1 DM, a viral infection in genetically 
susceptible individuals was hypothesized as 
triggering the disease. Human cytomegalovirus 
(HCMV) can infect and alter functions of poly 
morphonuclear leukocytes, lymphocytes and 
macrophages.Type 1 diabetes (T1D) is one of the most 
common chronic diseases in developed countries and 
represents about 10% of all cases of diabetes. It is 
caused by a selective destruction of insulin-producing 
beta cells (β-cells) in the pancreas (1). An increasing 
incidence of T1D has been observed in the last few 
decades, especially in young individuals (less than 
five years old) (2). The cause of T1 Dis still unknown. 
Several factors interact and lead to the development of 
the disease. An inflammatory is let infiltrate (insulitis) 
can be observed at the symptomatic onset of T1D, and 
reflects the immune response to β-cells (3). An 
autoimmune destructive process, which plays a 
central role in the development of T1D, is facilitated 
by the subject’s own genetic susceptibility and by 
non-genetic factors. Non-genetic factors include viral 
infections, toxic chemicals, and others (4). Specific 
viruses can infect humans and may cause diabetes 
mellitus through different mechanisms, such as 
pancreatitis or hepatitis and their subsequent 
complications (5). Cytomegalo-virus (CMV) is an 
important factor thought to be associated with type I 
diabetes mellitus, owing to its ability to induce 
immunological damage to β-cells  (6)  CMV is an 
ubiquitous virus in the herpes group, causing chronic 
life-long infection in affected participants. It is a 
widely distributed virus, belonging to herpes virinae, 
subfamily of herpes viridae. Molecular mimicry is one 
of the principal immunological mechanisms that lead 
to destruction of pancreatic β-cells. This mimicry could 
be in volvedincy to megalo virus-induced diabetes by 
inducing is reactive antibodies. The loss of T-cell 
tolerance to self (GAD65) may be due to processing 
and presentation of a molecular mimic of cytomegalo 
virus protein pUL57 by dendritic cells (7). A Real-time 
PCR assay was described as an accurate and rapid test 
for CMV quantization by Leruez-Ville et al (2004) (8) 
The purpose of this study is to find out the association 
between cytomegalovirus and type 1 diabetes mellitus 
with comparison to healthy subjects, and to correlate 
its level with different clinical and laboratory 
parameters. 
 
MATERIALS & METHODS 
This study included 68 children and adolescents who 
were classified into two groups. Group I comprised 53 
patients who had already been diagnosed as diabetic 
according to the standard ADA criteria and had 
regular follow up in the pediatric endocrinology 
outpatients' clinic, Minia University children's 
hospital, Egypt. Group II comprised 15 apparently 
healthy subjects, age and sex matched to the diseased 
group. Subjects were collected during the period from 
September 2013 to December 2013. According to the 
onset of diabetes, we divided the diabetic group into 
two sub-groups. Group Ia (newly diagnosed; duration 
of disease < 1 year) comprised 20 patients; 10 were 
males (50 %), and 10 were females (50 %), with ages 
ranging from 6-18 years (mean 11.4 ± 4.2). Group 
Ib(their duration of disease >1 year) comprised 33 
patients; 17 were males (49 %), and 18 were females 
(51%), with ages ranging from 6 to 17 years (mean 
12.3± 5.1). Informed consent was obtained from every 
subject enrolled in this study. The studied groups 
were subjected to the following: history taking, 
clinical examination and laboratory investigations. 
Random blood glucose levels (Colorimetric, Human, 
Germany) were assayed using a fully automated 
clinical chemistry auto-analyzer system Konelab 20i 
(Thermo Electron Incorporation, Finland) (9).  HbA1c 
% was determined, as a parameter for glycemic 
control, by using resin column chromatography. Kit 
contents were supplied by TECO DIAGNOSTICS, 
California; USA (10).  Five mL of blood samples from 
the diabetic children were collected and centrifuged at 
5000 rpm. Serum samples were collected in sterile 
tubes; then DNA was extracted using the QIAamp 
Min elute kit protocol. 
Principle Real time PCR 
Procedure: CMV Quantitative Real Time PCR was 
used according to literature (OD-0002-02) from Life 
River. 17.5 µL of Reaction Mix CMV was used. 
Reaction was mixed with 0.2 µL of PCR enzyme mix 
and 0.5 µL of internal control then 6.8 µL of extracted 
DNA for a total volume of 25 µL. A positive control 
was defined as 107 copies/mL. To generate a standard 




curve, a four-dilution standard was used. The real-
time PCR instrument was operated according the 
thermal profile in the manual Ref (OD-0002-02). Each 
sample was spun down briefly in order to collect the 
Master Mix in the bottom of the reaction tubes, then 
the following protocol was performed in the 
instrument: 37°C for 2 min 1 cycle, 94 °C for 2 min 1 
cycle at 94°C for 15 sec and at 60 °C for 1 min 40 cycles 
Statistical Methods: The data were coded and verified 
prior to data entry. All statistical analyses were 
carried out using the Statistical Package for Social 
Sciences (SPSS/Windows Version 19.0.0, SPSS Inc., an 
IBM Company). Microsoft excel 2013 was used for 
drawing figures. Continuous variables were 
presented as mean followed by standard deviation 
(SD), and categorical variables were presented as 
frequency and percentage. For qualitative data, chi-
square (κ2) was used: For quantitative data: 
Independent-Samples T test (for two groups) used in 
person correlation for correlation between two 
quantitative variables. Two-tailed partial correlation 
coefficients (r) adjusted for age, sex and BMI were 
used to assess the relationships between 25-hydroxy 
vitamin D and other variables. P-value < 0.001 was 
considered significant, and P-value > 0.001 was 
considered in significant. Kendl's test: was used for 
correlation between quantitative and qualitative 
variables. 
RESULTS 
Diabetic children had significantly higher weight and 
lower height than the control group (P < 0.001 for 
both). On the contrary, the differences between the 
diabetic and control groups as regards BMI and waist 
circumference was insignificant (P =0.4 and 0.3 
respectively; Table 1). Table 2 shows that diabetic 
children, compared to the control group, had 
significantly higher fasting blood sugar, HbA1c %, 
and positivity of cytomegalovirus (45% vs7%). 
Duration: The current study found that newly 
diagnosed diabetic children, compared to those with 
longer duration of diabetes, had significantly higher 
frequency of cytomegalovirus (70% vs 30%), lower 
fasting blood sugar, and higher HbA1c% (P< 0.001, 
Table 3).  
 
TABLE 1.COMPARISON BETWEEN THE DIABETIC CHILDREN AND THE CONTROLS                                                                    
AS REGARD SOME CLINICAL PARAMETERS 






6-12 years. No (%) 
12-18 years. No (%) 
 
17 (32 %) 
36 (68 %) 
 
5 (33%) 





Male         No  (%) 
Female     No (%) 
 
 
27 (51 %) 
26 (49 %) 
 
 
10 (67 %) 





Wt t(kg) mean±(SD) 40.4±16.2 37.9±12.6 <0.001* 
 
Height(cm)Mean±SD) 142.8±21.1 149.3±13.1 <0.001* 
BMI(kg/m2)(Mean±SD) 18.9±4.3 16.8±2.7 0.4 
Waist circumference 
(cm)(Mean±SD) 
65±10.9 68.1±8.4 0.3 
*Significant 
 






TABLE 2.COMPARISON BETWEEN THE DIABETIC CHILDREN AND THE CONTROLS AS REGARD SOME LABORATORY 
PARAMETERS 
Laboratory parameter Group I, 
No=53(Mean±SD) 
Group II, No=15 
(Mean±SD) 
P Value 
Cytomegalovirus positivity No (%) 24(45 %) 1(7 %) 0.003* 
Fasting blood sugar(mg/dl) 229.5±92.6 92.8±7.6 <0.001* 
HbA1c (%) 8.7±1.8 5.7±0.6 <0.001* 
• Significant 
 
TABLE 3.COMPARISON BETWEEN NEWLY DIAGNOSED AND THOSE WITH DURATION > 1 YEAR AS REGARD 





























Parameter Group Ia 
(duration < 1 year) 
No=20/cases     
Group Ib 
(duration > 1 year) 
No = 33 (+ve CMV) 
P value 
Age (year) 
6-12. No (%) 
12-18 No (%) 
 
4(20%), 3 (75%) 
16(80%), 11(68.7) 
 
10 (33%), 4 (40%) 




Male No (%) 
Female No (%) 
 
10 (50%), 3 (30%) 
10 (50%), 10 (100%) 
 
16 (48%), 3 (18%) 
17 (52%), 7 (43%) 
 
0.915 





Family history of DM:  
Positive No (%) 









Cytomegalovirus positivity No 
(%) 
14(70%) 10(30%) <0.002 
HbA1c%    Mean±SD) 10.7±1.3 7.7±0.4 <0.001* 
Fasting blood sugar(mg/dl)      
(Mean±SD) 
121.2±7.9 259.6±75.5 <0.001* 




On the contrary, there were insignificant differences 
between these groups as regards age, dose of insulin, and 
family history of DM. Table 4 shows that there were 
significant positive correlations of cytomegalovirus 
positivity with fasting blood sugar and HbA1c%, and 
significant negative correlations with duration of disease 




TABLE 4. CORRELATIONS BETWEEN POSITIVITY OF CYTOMEGALOVIRUS AND  SOME CLINICAL AND 
LABORATORY PARAMETERS AMONG THE DIABETIC CHILDREN 
Parameter positivity of cytomegalovirus 
     R Pvalue 
Duration of diabetes (months) -0.24 0.02* 
Fasting blood sugar (mg/dl) 0.76 <0.001* 
HbA1c (%) 0.86 <0.001* 
Insulin dose (IU/kg/day) -0.38 0.02* 
 
DISCUSSION 
T1D is an autoimmune disease, which implies a role 
of immune response effectors in the pathogenic 
processes and a failure of tolerance towards β-cell 
antigens. There is interplay between immune 
response, genetic and environmental factors. Several 
teams paid attention to the relationship between 
viruses and type 1 diabetes, and their role in the 
pathogenesis of the disease.[11]In the current study, the 
diabetic children (group I)were found to have higher 
weight and shorter height than the control group 
(group II; Table 1). This result was in agreement 
withPaulinoMFVM et al (2006)[12]who found that 
diabetic children were higher in weight and shorter in 
height in comparison to healthy children. Concerning 
BMI and waist circumference, there were insignificant 
difference between group I and group II (P> 0.05). 
This result was in agreement with that reported in 
lit.[13]Regarding laboratory parameters. Table 2 
showed that diabetic children (group I) had 
significant higher fasting blood sugar and HbA1c % 
than the control group (group II). This was in 
agreement with CiechanowskiPC 
(2002)[14]Cytomegalovirus tested positive in 45 % of 
the diabetic patients versus (7%) of the control group, 
a statistically significant difference (P = 0.003). This 
finding was in agreement withAhmad-
AbakurEH(2014), (15) who found that the positive 
rate of IgG against cytomegalo virus in the study 
group (diabetic patients) was 37% while it was 14.8% 
among a control group, indicating statistically 
significant association between IgG antibodies of 
cytomegalovirus and diabetes mellitus type I (P value 
0.025). The study reveals significant relation (P value 
0.003) of cytomegalovirus IgG antibodies with type I 
diabetes mellitusin age group (5-9 years) in Sudanese 
children. (15) 
Regarding the duration of diabetes, we found that 
newly diagnosed diabetic children had significantly 
higher frequency of cytomegalovirus, compared to 
those with longer duration of diabetes, by 70% over 
30%. This can be explained in that Human CMV 
(HCMV) plays an important role in diabetogenesis, 
where it was postulated that there is T-cell cross-
reactivity between Human CMV (HCMV) and GAD 
65 in pancreatic islet β-cells. HCMV-derived epitope 
could be naturally processed by dendritic cells and 
recognized by GAD65 reactive T-cells. Thus, HCMV 
may be involved in the loss of T-cell tolerance to 
autoantigen GAD65 by a mechanism of molecular 
mimicry leading to autoimmunity.[7]In 2008, 
Aarnisaloet al  (16) analyzedspecific anti-CMV IgG 
antibodies in 169 serum samples from children who 
had developed the first T1D-associated autoantibody 
by the age of 2 years, and, in parallel, in 791 serum 
controls from healthy children. Serological, 
immunological, histological signs of autoimmunity 
and allograft rejection appeared concomitantly with 
early CMV infections in type 1 diabetic patients 
receiving pancreas allograft. This observation 
suggests that persistent CMV infections might be 
relevant to the pathogenesis of type 1 diabetes. Chen 
et al, (2012) (16) indicated that cells are damaged 
directly by viral infection, as the pancreas is a target 
organ of viral infection through induction of pro-
inflammatory cytokines, or the cytotoxic activated 
effects or lymphocytes. 




Regarding the duration of diabetes, the current study 
found that newly diagnosed diabetic children had 
significantly higher levels of cytomegalovirus than 
those with duration >1 year (P=002). This could be 
explained by the finding by Hjelmesaeth et al (2004) 
(17) who foundthat asymptomatic cytomegalovirus 
infection is associated with increased risk of new-onset 
type I diabetes and impaired insulin release after renal 
transplantation. As regards other parameters, the 
newly diagnosed had significantly lower fasting blood 
sugar and higher HbA1c% than those with long 
duration of diabetes (P < 0.001, Table 3). On the 
contrary, there were insignificant differences between 
these groups as regards age, dose of insulin, and 
family history of DM. Table 4 shows that there were 
significant positive correlations between 
cytomegalovirus levels with fasting blood sugar and 
HbA1c% and significant negative correlations with the 
duration of disease and insulin dose. This could be 
explained in that CMV infection apparently did not 
cause direct destruction of β-cells but was leading to 
changing in production of insulin. 
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